Compile Data Set for Download or QSAR
maximum 50k data
Found 120 with Last Name = 'stuerzebecher' and Initial = 'j'
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98601((2S)-6-[[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-aminoethoxy)...)
Affinity DataKi:  4.70nM ΔG°:  -47.4kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98599((2S)-6-amino-2-[[(2R)-2-(benzylsulfonylamino)-3-hy...)
Affinity DataKi:  6.80nM ΔG°:  -46.5kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98587((2R)-N-[(1S)-1-(benzyloxymethyl)-2-[(4-carbamimido...)
Affinity DataKi:  6.80nM ΔG°:  -46.5kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98600((2S)-2-[[(2R)-2-(benzylsulfonylamino)-3-hydroxy-pr...)
Affinity DataKi:  7nM ΔG°:  -46.4kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98600((2S)-2-[[(2R)-2-(benzylsulfonylamino)-3-hydroxy-pr...)
Affinity DataKi:  8.90nM ΔG°:  -45.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98590((2S)-3-benzyloxy-2-[[(2R)-2-(benzylsulfonylamino)-...)
Affinity DataKi:  11nM ΔG°:  -45.3kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98583(4-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  13nM ΔG°:  -44.9kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98593(US8476306, 6.19 | methyl 4-[[(1R)-2-[[(1S)-2-[(4-c...)
Affinity DataKi:  20nM ΔG°:  -43.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98588((2S)-3-amino-2-[[(2R)-2-(benzylsulfonylamino)-3-hy...)
Affinity DataKi:  21nM ΔG°:  -43.7kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98584(3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  21nM ΔG°:  -43.7kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM50231520((R)-N-[(S)-1-(4-carbamimidoyl-benzylcarbamoyl)-2-h...)
Affinity DataKi:  22nM ΔG°:  -43.6kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98599((2S)-6-amino-2-[[(2R)-2-(benzylsulfonylamino)-3-hy...)
Affinity DataKi:  24nM ΔG°:  -43.3kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM50231520((R)-N-[(S)-1-(4-carbamimidoyl-benzylcarbamoyl)-2-h...)
Affinity DataKi:  25nM ΔG°:  -43.2kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98603(3-amino-N-[4-[[(2S)-2-[[(2R)-2-(benzylsulfonylamin...)
Affinity DataKi:  25nM ΔG°:  -43.2kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98587((2R)-N-[(1S)-1-(benzyloxymethyl)-2-[(4-carbamimido...)
Affinity DataKi:  28nM ΔG°:  -43.0kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98584(3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  30nM ΔG°:  -42.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98589((2S)-2-[[(2R)-2-(benzylsulfonylamino)-3-hydroxy-pr...)
Affinity DataKi:  30nM ΔG°:  -42.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98596((2R)-N-[2-[(4-carbamimidoylphenyl)methylamino]-2-o...)
Affinity DataKi:  31nM ΔG°:  -42.7kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98594((2R)-N-[2-[(4-carbamimidoylphenyl)methylamino]-2-o...)
Affinity DataKi:  32nM ΔG°:  -42.6kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM50110015(CHEMBL158936 | N-(BENZYLSULFONYL)SERYL-N~1~-{4-[AM...)
Affinity DataKi:  36nM ΔG°:  -42.3kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98588((2S)-3-amino-2-[[(2R)-2-(benzylsulfonylamino)-3-hy...)
Affinity DataKi:  36nM ΔG°:  -42.3kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98583(4-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  38nM ΔG°:  -42.2kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98601((2S)-6-[[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-aminoethoxy)...)
Affinity DataKi:  42nM ΔG°:  -42.0kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98591(3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  58nM ΔG°:  -41.2kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98595((2R)-N-[2-[(4-carbamimidoylphenyl)methylamino]-2-o...)
Affinity DataKi:  58nM ΔG°:  -41.2kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98590((2S)-3-benzyloxy-2-[[(2R)-2-(benzylsulfonylamino)-...)
Affinity DataKi:  61nM ΔG°:  -41.0kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98591(3-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  75nM ΔG°:  -40.5kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98581(US8476306, 6.6 | methyl 2-[[(1R)-2-[[2-[(4-carbami...)
Affinity DataKi:  83nM ΔG°:  -40.3kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98585((2R)-N-[(1S)-2-[(4-carbamimidoylphenyl)methylamino...)
Affinity DataKi:  89nM ΔG°:  -40.1kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProthrombin(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98590((2S)-3-benzyloxy-2-[[(2R)-2-(benzylsulfonylamino)-...)
Affinity DataKi:  100nM ΔG°:  -39.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against ThrombinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98598((2R)-N-[2-[(4-carbamimidoylphenyl)methylamino]-2-o...)
Affinity DataKi:  100nM ΔG°:  -39.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98592(4-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  100nM ΔG°:  -39.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98603(3-amino-N-[4-[[(2S)-2-[[(2R)-2-(benzylsulfonylamin...)
Affinity DataKi:  110nM ΔG°:  -39.6kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98597((2R)-N-[2-[(4-carbamimidoylphenyl)methylamino]-2-o...)
Affinity DataKi:  110nM ΔG°:  -39.6kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98596((2R)-N-[2-[(4-carbamimidoylphenyl)methylamino]-2-o...)
Affinity DataKi:  110nM ΔG°:  -39.6kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98589((2S)-2-[[(2R)-2-(benzylsulfonylamino)-3-hydroxy-pr...)
Affinity DataKi:  110nM ΔG°:  -39.6kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98586((2R)-2-[[4-(aminomethyl)phenyl]methylsulfonylamino...)
Affinity DataKi:  120nM ΔG°:  -39.4kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM50110015(CHEMBL158936 | N-(BENZYLSULFONYL)SERYL-N~1~-{4-[AM...)
Affinity DataKi:  120nM ΔG°:  -39.4kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98604(2-[4-[[(1R)-2-[[2-[4-[(3-amino-4-methoxy-benzoyl)a...)
Affinity DataKi:  130nM ΔG°:  -39.2kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM50110015(CHEMBL158936 | N-(BENZYLSULFONYL)SERYL-N~1~-{4-[AM...)
Affinity DataKi:  150nM ΔG°:  -38.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98580(4-[[(1R)-2-[[2-[(4-carbamimidoylphenyl)methylamino...)
Affinity DataKi:  150nM ΔG°:  -38.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98578(3-[[(1R)-2-[[2-[(4-carbamimidoylphenyl)methylamino...)
Affinity DataKi:  160nM ΔG°:  -38.7kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98579(US8476306, 6.4 | methyl 4-[[(1R)-2-[[2-[(4-carbami...)
Affinity DataKi:  180nM ΔG°:  -38.4kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98602(3-amino-N-[4-[[2-[[(2R)-3-amino-2-(benzylsulfonyla...)
Affinity DataKi:  180nM ΔG°:  -38.4kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98602(3-amino-N-[4-[[2-[[(2R)-3-amino-2-(benzylsulfonyla...)
Affinity DataKi:  180nM ΔG°:  -38.4kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98600((2S)-2-[[(2R)-2-(benzylsulfonylamino)-3-hydroxy-pr...)
Affinity DataKi:  200nM ΔG°:  -38.1kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against PlasminMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine protease 1(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98595((2R)-N-[2-[(4-carbamimidoylphenyl)methylamino]-2-o...)
Affinity DataKi:  210nM ΔG°:  -38.0kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against TrypsinMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98593(US8476306, 6.19 | methyl 4-[[(1R)-2-[[(1S)-2-[(4-c...)
Affinity DataKi:  230nM ΔG°:  -37.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase plasminogen activator surface receptor(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98592(4-[[(1R)-2-[[(1S)-2-[(4-carbamimidoylphenyl)methyl...)
Affinity DataKi:  230nM ΔG°:  -37.8kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against Plasminogen activator urokinaseMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen(Rattus norvegicus)
The Medicines

US Patent
LigandPNGBDBM98587((2R)-N-[(1S)-1-(benzyloxymethyl)-2-[(4-carbamimido...)
Affinity DataKi:  270nM ΔG°:  -37.4kJ/moleT: 2°CAssay Description:Inhibition constant of the compound against PlasminMore data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 120 total ) | Next | Last >>
Jump to: